Johanna Goldfarb, MD
Center for Pediatric Infectious Diseases
Cleveland Clinic Main Campus
Mail Code: S25
9500 Euclid Avenue
Cleveland, OH 44195
Phone: (216) 444-5437
Johanna Goldfarb, MD, is head of Pediatric Infectious Diseases in the Pediatric Institute at the Cleveland Clinic Children's Hospital (CCCH). She is a Full Professor at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University (CCLCM). Dr. Goldfarb is a member of Medical Student Portfolio Review Committee (MSPRC) for promotion of the medical students, as well as the Academic Promotions committee for the Cleveland Clinic Lerner College of Medicine for staff physicians.
Dr. Goldfarb is board certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include clinical pediatric infectious diseases and infections in immunocompromised children. Her research interests include infections in children with cancer and after transplantation. Dr. Goldfarb has received many teaching awards in her career and also the Cleveland Clinic's Bruce Hubbard Stewart Award " in recognition of her ability to combine sensitivity and compassion with knowledge and skill in the practice of medicine" .
Education & Fellowships
Fellowship - Albert Einstein College of Medicine
New York, NY USA
Residency - Hershey Medical Center
Residency - New York Downtown Hospital, New York Hospital - Cornell Medical Center
New York, NY USA
Medical School - Johns Hopkins University School of Medicine
Baltimore, MD USA
Undergraduate - Johns Hopkins University
Baltimore, MD USA
- Pediatrics- Pediatric Infectious Diseases
Pediatric infectious diseases, viral infections, bone and joint infections, congenital infections, infections in immunocompromised hosts
Awards & Honors
- Excellence in Teaching, New York Medical College, 1986
- Department of Pediatrics Teaching Excellence Award, Case Western Reserve University, 1991
- Distinguished Teacher, Department of Pediatrics, Cleveland Clinic Foundation, 1994
- Steward Scholar, Cleveland Clinic Foundation, 1994-1995
- Cleveland Clinic Foundation Division of Pediatrics Chairmen’s Award for Promoting Research,1998
- Residents award for outstanding teacher, Pediatrics, Cleveland Clinic, 2002
- Bruce Hubbard Stewart Award in recognition of ability to combine sensitivity and compassion with knowledge and skill in the practice of medicine 2005
- Residents award for outstanding teacher, Pediatrics, Cleveland Clinic, 2003
- Distinguished Teaching Award Pediatrics, Cleveland Clinic: Section of Pediatric Infectious Diseases, 2003-2004
- Award of Excellence: Scholars Collaborative in Teaching and Learning, 2004-2005 America's Best Doctors
- Fellow, American Academy of Pediatrics
- Fellow, Infectious Diseases Society of America
- Member, Pediatric Infectious Diseases Society
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/15/2016, Dr. Goldfarb has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.